chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLU4
Symptoms: Chest discomfort, Lip swelling, Pharyngeal swelling
Clinical narrative: lip swelled; throat swelled; had a funny feeling in the chest; Initial information received on 25-Oct-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case is linked to cases 2023SA336263 and 2023SA325293.  This case involves a female patient of an unknown age who experienced lip swelled, throat swelled and had a funny feeling in the chest after receiving Influenza Quadrival A-B Vaccine [Fluzone Qiv].  The patient's past vaccination(s) included COVID shot. The patient's past medical history, medical treatment(s) and family history were not provided.   On an unknown date in 2009, the patient received a unknown dose of suspect Influenza Quadrival A-B Vaccine (strength, expiry date and lot number not reported) via unknown route in unknown administration site as Prophylactic vaccination (immunization). Information on the batch number was requested.  On an unknown date the patient developed lip swelled (lip swelling), throat swelled (pharyngeal swelling) and had a funny feeling in the chest (chest discomfort) (unknown latency).  Action taken: not applicable.  An allergy medication in a larger quantity for 7-days was received as corrective treatment for the events (lip swelled, throat swelled) and It was not reported if the patient received a corrective treatment for the event (had a funny feeling in the chest).  At time of reporting, the outcome was Unknown for all events
Age: 17.0
Sex: M
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: FLUBLOK given to a 17-year-old with no reported adverse event; Initial information received on 25-Oct-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves, influenza quadrivalent recombinant vaccine [Flublok qiv] given to a 17-year-old (male) with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.  On 25-Oct-2023, the patient received 0.5 ml total dose of suspect influenza quadrivalent recombinant vaccine (strength, form: unknown) (lot: QFAA2332, expiry date: 30-Jun-2024) via intramuscular route in the deltoid Nos for Immunization and flublok given to a 17-year-old with no reported adverse event (product administered to patient of inappropriate age) (latency: same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 73.0
Sex: M
Vaccine: FLU3, FLU4
Symptoms: No adverse event, Wrong product administered
Clinical narrative: a patient received FLUZONE QUADRIVALENT PFS, but in actuality desired to have Fluzone High-Dose PFS with no reported adverse event; Initial information received on 26-Oct-2023 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional.  This case involves a 73 years old male patient where reporter reported patient received influenza quadrival a-b vaccine [fluzone qiv] but in actuality desired to have influenza usp trival a-b high dose subvirion vaccine [fluzone high dose] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included tozinameran (Pfizer biontech covid-19 vaccine) for Prophylactic vaccination.  On 23-Oct-2023, the patient received 0.5 ml dose of suspect influenza quadrival a-b vaccine Suspension for injection (lot- U8192AA and expiration date- 20-Jun-2023) via intramuscular route in the left deltoid (strength: not provided) for Immunisation (wrong product administered) (latency- same day).  On an unknown date, the patient received a dose of suspect influenza usp trival a-b high dose subvirion vaccine Suspension for injection in pre-filled syringe lot number not reported via unknown route in unknown administration site (dose, strength and expiration date: not provided) for Immunisation.  Action taken- not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MEN
Symptoms: No adverse event, Wrong product administered
Clinical narrative: nurse mentioned that quadracel was meant to be given to the patient but nurse ended up getting and giving the menquadfi with no reported adverse event; Initial information received on 26-Oct-2023 regarding an unsolicited valid  non-serious case received from a Nurse.  This case involves a 4 years old male patient and nurse reported that diphtheria-15/tetanus/5 Hybrid Ac Pertussis/IPV (Mrc5) Vaccine [Quadracel] was meant to be given to the patient but ended up getting and giving the Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Measles Vaccine Live (Enders-Edmonston), Mumps Vaccine Live (Jeryl Lynn), Rubella Vaccine Live (Wistar Ra 27/3), Varicella Zoster Vaccine Live (Oka/Merck) (Proquad); Hepatitis B Vaccine Rhbsag (Yeast) (Recombivax) And Hepatitis A Vaccine Inact (Vaqta) for Prophylactic vaccination.  On 25-Oct-2023, the patient received a unknown (dose 1) dose of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine Solution for injection (strength: standard, frequency: once, lot U7903AC, expiry date: 31-Dec-2025) instead of diphtheria-15/tetanus/5 Hybrid Ac Pertussis/IPV (Mrc5) Vaccine Suspension for injection (strength, lot number, expiry date: unknown)via intramuscular route in the left deltoid as Immunization (wrong product administered) (latency: same day). Information on the batch number was requested.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.33
Sex: M
Vaccine: UNK
Symptoms: No adverse event, Product preparation error, Single component of a two-component product administered
Clinical narrative: hib component of the pentacel was not mixed and was not given to the consumer with no reported adverse event; Initial information received on 26-Oct-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 4 months old male patient and reporter reported hib component of the Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] was not mixed and was not given to the consumer with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine conj 20v (crm197) (prevnar 20) for prophylactic vaccination; and rotavirus vaccine live reassort oral 5v (rotateq) for prophylactic vaccination.  On 23-Oct-2023, the patient received 0.5 ml of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine Suspension for injection (lot number: UJ861AA) (Expiry date: 30-Mar-2024) (Strength: standard) (Frequency: once) via intramuscular route in the left thigh for immunization.  On 23-Oct-2023, the reporter reported hib component of the Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine was not mixed and was not given to the consumer with no reported adverse event (product preparation error) (latency: same day).  It was reported, LVN called in because the HIB component of the PENTACEL was not mixed and was not given to the consumer. Caller wanted to know about what to do next. Provided the information via SRD, and information was also sent to the caller via email. This inquiry was submitted to PV since the vaccine was given inappropriately without the HIB component.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 69.0
Sex: M
Vaccine: FLU4
Symptoms: Allergy test positive, Unevaluable event
Clinical narrative: patient tested positive for Alpha-gal Allergy; Initial information received on 26-Oct-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 69 years old male patient tested positive for alpha-gal allergy after receiving INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (formulation, strength, expiry date, lot number not reported) via unknown route in unknown administration site for Immunization. The information on batch number was requested.  On an unknown date the patient tested positive for alpha-gal allergy (food allergy) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  Relevant laboratory test results included: Food allergy - On an unknown date: Positive  Reportedly "Caregiver (wife) calls on behalf of the patient to confirm if FLUZONE HIGH DOSE Quadrivalent has animal derivative in it other than chicken egg, or if it does have gelatin content. She states that they went to their primary doctor first where patient received the FLUZONE HIGH DOSE. Then after their primary doctor visit, they went straight to their allergist where patient tested positive for Alpha-gal Allergy. Hence, she wants to make sure if the product has animal derivative in it other than chicken egg, or if it does have gelatin content. "  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (patient tested positive for Alpha-gal Allergy).  At time of reporting, the outcome was Unknown for the event patient tested positive for alpha-gal allergy.
Sex: U
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: given an extra dose of FLUZONE QIV-NP to a patient with no reported adverse event; Initial information received on 26-Oct-2023 regarding an unsolicited valid  non-serious case received from a nurse.  This case involves an unknown age and unknown gender patient who was given an extra dose of Influenza Quadrival A-B Vaccine [Fluzone Qiv] to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an 0.5 ml  total (1 X) of suspect Influenza Quadrival A-B Vaccine Suspension for injection (lot number: UT8040MA) (Expiry date: 30-Jun-2024) (strength: standard) (Frequency: once) via unknown route in unknown administration site for immunization.  On an unknown date, the patient was given an extra dose of Influenza Quadrival A-B Vaccine to a patient with no reported adverse event (extra dose administered) (unknown latency).  It was reported, Nurse called to inform that they have given an extra dose of FLUZONE QIV-NP to a patient. Licensed Vocational Nurse told that the patient received the vaccine 4 weeks ago from another facility and the patient came to their clinic and was injected an extra dose of the vaccine. Licensed Vocational Nurse informed that she cannot share any information on the patient and only provided the lot number, expiration date and NDC number of the vaccine. This situation is reported as a medication error due to vaccine double dosing.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: U
Vaccine: FLU3
Symptoms: Extra dose administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: One year old child received their second dose of FLUZONE QUADRIVALENT 14 days after the first dose with no reported adverse event; Initial information received on 26-Oct-2023 regarding an unsolicited valid non-serious case received from a Pharmacist.  This case involves a 1 years old and unknown gender patient where reporter reported one year old child received their second dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] 14 days after the first dose with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose 2 of suspect influenza quadrival a-b multidose vaccine preserved Suspension for injection lot number not reported via unknown route in unknown administration site (dose, strength and expiration date: not provided) for Immunisation (inappropriate schedule of product administration). There will be no information available on the batch number for this case.  Action taken- Not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient received both vaccines, spikevax and fluzone HD in the same arm (left arm) on Saturday, November 4th. The following day, Sunday, 11/5/23, she started to experience redness, pain at the injection site, and has been worsening since then. She stopped into the pharmacy today to have me look at it, and her upper left arm is swollen, red, painful and warm to the touch. She didn't report having a fever or any other symptoms, but I recommended her to be seen by a doctor today in case it's turning into an infection which would need antibiotics. She did go to express care today and was prescribed cephalexin.
Age: 74.0
Sex: F
Vaccine: FLUA4
Symptoms: Arthralgia, Mobility decreased
Clinical narrative: The patient complained of severe pain in her shoulder area and difficulty raising her arm.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Back pain, COVID-19, Cough, Eye pain, Facial pain
Clinical narrative: 11/3/23 had fever 100.9, runny nose, severe back ache, cough, body ache.  Took tylenol  11/4/23 fever 100.3 took tylenol. Tested positive on home covid test 11/5- 99.7 temp, severe cold, congestion, cough, runny nose, left eye brow area swollen painful 11/6- runny tap nose, body ache, cough, finally prescribed paxlovid 11/7- runny nose, left eye painful. By 6pm feeling a bit better.  Question is: did vaccine cause positive test or was it really covid infection after vaccine.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: 11/3/23 had fever 100.9, runny nose, severe back ache, cough, body ache.  Took tylenol  11/4/23 fever 100.3 took tylenol. Tested positive on home covid test 11/5- 99.7 temp, severe cold, congestion, cough, runny nose, left eye brow area swollen painful 11/6- runny tap nose, body ache, cough, finally prescribed paxlovid 11/7- runny nose, left eye painful. By 6pm feeling a bit better.  Question is: did vaccine cause positive test or was it really covid infection after vaccine.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Swelling face
Clinical narrative: 11/3/23 had fever 100.9, runny nose, severe back ache, cough, body ache.  Took tylenol  11/4/23 fever 100.3 took tylenol. Tested positive on home covid test 11/5- 99.7 temp, severe cold, congestion, cough, runny nose, left eye brow area swollen painful 11/6- runny tap nose, body ache, cough, finally prescribed paxlovid 11/7- runny nose, left eye painful. By 6pm feeling a bit better.  Question is: did vaccine cause positive test or was it really covid infection after vaccine.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Injection site pain
Clinical narrative: A week after vaccination, injection site was extremely tender and felt like a burning sensation until current date (about two weeks time) and is not subsiding
Age: 69.0
Sex: F
Vaccine: UNK
Symptoms: Tinnitus
Clinical narrative: Ringing in the ears
Age: 9.0
Sex: M
Vaccine: FLUC4
Symptoms: Dizziness, Face injury, Fall, Syncope
Clinical narrative: Patient was fine during and after giving vaccine, but after they left the pharmacy, the front end manager  of the store called us over due to a 'patient fainting in the aisle'.  The patient had fainted, hit his right cheek into a shelf and collapsed on the floor (per mom).  Patient was awake, but dizzy when I approached.  We applied cold compresses to his face and kept him alert until the EMS arrived.  Mom decided not to have them take him to the hospital, and she took him home.  I followed up with mom around 3pm and she said he was back to his normal self.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: pt already received one dose of Pfizer Comirnaty (10/3/23) and returned to pharmacy and also received Moderna Spikevax (11/7/23).   Pt worried over receiving two doses
Age: 22.0
Sex: F
Vaccine: TYP
Symptoms: Expired product administered, No adverse event
Clinical narrative: RN administered expired Typhoid vaccine - vaccine expiration date: 11/2/2023; vaccine administration date 11/6/2023; No adverse effect noted by patient as of 11/7/2023; Patient informed via phone call regarding need to revaccinate patient for Typhoid
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Blood pressure increased, Blood urine present, Chest X-ray normal, Chronic obstructive pulmonary disease
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram thorax normal, Condition aggravated, Culture urine positive, Dehydration
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dizziness postural, Dysgeusia, Dyspnoea, Electrocardiogram normal
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypercalcaemia, Immunisation reaction, Lipase normal, Lung opacity, Memory impairment
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test abnormal, Microscopy, N-terminal prohormone brain natriuretic peptide normal, Nitrite urine absent, Ovarian cyst
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Renal cyst, Renal hamartoma, Renal mass, Sinus rhythm
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Small airways disease, Spontaneous haemorrhage, Troponin I increased, Urine analysis abnormal, Vertigo
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, White blood cells urine positive
Clinical narrative: Per clinic provider, "Patient ID: Patient is a 79 y.o. female who presents for Dizziness (COVID vaccine today at 15:20pm. /20 minutes afterward, she started feeling dizzy, blurry vision, feeling flushed, hard to breathe ).  HPI I was called to the room after pt experienced a side effect from COVID vaccine.  Approximately 20 minutes after vaccine was given she had blurry vision and shortness of breath.   Pt's daughter admits that she went into "a coma" after her 2nd COVID vaccine.  Pt tolerated her 1st COVID vaccine fine.  In reviewing her chart she also received a 3rd and 4th vaccine without complications.  Pt did have flu shot approx 2 weeks ago and did not have any side effects.   Pt states that she was in her normal state of health until after the vaccine.  Feels that things are spinning and she has SOB.   Vital signs show an O2 saturation down to 87% on RA.  Her BP was also elevated.  She has also noticed since the vaccine a metallic taste in her mouth. Need for COVID-19 vaccine (Primary)  Dizziness  SOB (shortness of breath)  Pt was monitored for a brief time and O2 sats continued to drop down to 87% on RA with the highest getting to 94-95%.  BP continues to remain elevated.  She continues to complain of SOB and dizziness. In reviewing chart it appears that she had a conversion reaction after the vaccine from 2021.  She was given Ativan at that time and symptoms resolved with a negative work-up.   Recommend that she be further evaluated in the ER along with baseline labs and some fluids.  Patient went to Medical Center emergency room. Per ER doctor,  "Final diagnoses: [R06.02] Shortness of breath [T50.B95A] Adverse effect of COVID-19 vaccine [E83.52] Hypercalcemia [R41.3] Memory changes [D17.71] Angiomyolipoma of right kidney [N28.1] Kidney cysts [N83.202] Left ovarian cyst [E86.0] Dehydration"
Age: 5.0
Sex: M
Vaccine: DTAPHEPBIP, MMRV
Symptoms: Pruritus, Rash
Clinical narrative: ( Child had one dose of Dtap @ 3 months of age, today was 1st Pediarix) Mother returned with child to the clinic approximately 20 minutes of receiving vaccines for symptoms of full body rash and itching, no trouble breathing noted, patient alert and active. Administered 1 dose of Epipen Jr. 0.15 mg IM to left thigh @ 11:28 am. Lot #3GN002 exp. 7/2024. Patient tolerated well. Monitored patient for 35 minutes, vital signs normal and stable. Rash and itching completely resolved by 35 minutes. Child and Mother left clinic, advised to go to the ED if any new symptoms arise.
Age: 25.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Anxiety, Dizziness, Face injury, Fall, Haemorrhage
Clinical narrative: Patient walked to another aisle shortly after receiving her vaccines; as she walked back to sit down, patient felt lightheaded, fell, and hit her face on the floor. Her chin was slightly bleeding and scraped. Blood pressure was normal. Patient had an anxiety attack during the incident. EMT were called, they applied Neosporin and butterfly bandage on her chin. No hospitalization needed. Mom came by to pick up patient home.
Age: 25.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Scratch
Clinical narrative: Patient walked to another aisle shortly after receiving her vaccines; as she walked back to sit down, patient felt lightheaded, fell, and hit her face on the floor. Her chin was slightly bleeding and scraped. Blood pressure was normal. Patient had an anxiety attack during the incident. EMT were called, they applied Neosporin and butterfly bandage on her chin. No hospitalization needed. Mom came by to pick up patient home.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient received SDV 12+ vs recommended and approved dose 6 month - 11 yrs of age. no side effects reported since vaccine was given until today.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Patient had 4 moderna with our office, and a pfizer bivalent at another facility , not Primary Health 10-2-2022 and then came to our office for a moderna bivalent booster 2-28-2023 . I did not see her injection that she had somewhere else 10-2021.
Age: 34.0
Sex: M
Vaccine: FLUR4
Symptoms: Contusion, Skin discolouration
Clinical narrative: Patient came in the pharmacy on 11/7/23 and stated he has had a mark/bruise ever since day of administration on 10/11/23. He stated the mark is not causing any pain and is not getting any bigger, but that it still hasn't faded. Patient advised to contact the pharmacy if mark spreads or starts to hurt.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Death 5 days after being vaccinated
Age: 71.0
Sex: M
Vaccine: COVID19, FLU4, RSV
Symptoms: Chills, Pyrexia
Clinical narrative: Patient reported adverse reaction 11/6/23: patient reported fever/chills onset 10/24/23 approximately 10:30 PM. Patient denied taking ibuprofen or acetaminophen. Patient went to emergency room 10/24/23, received IV fluids, discharged 10/25/23.
Age: 87.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a second flu shot, no treatment necessary and no adverse affected reported
Age: 87.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a second flu shot, no treatment necessary and no adverse affects reported
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash, Injection site warmth, Rash
Clinical narrative: noticed red rash, like hives, approximately 2-3" below injection site. Was red and warm to the touch. Redness spread over whole arm during the following 3 days. No trouble breathing or swallowing
Age: 28.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Mobility decreased
Clinical narrative: Patient describes numb filling that went up along arm. She also states having difficulty lifting arm.
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dermatitis acneiform, Rash
Clinical narrative: Patient started having a rash on stomach and arms.  Patient went to a dermatologist who told him it was probably a reaction to the Spikevax immunization.  The rash started about 4 to 7 days after the immunization - patient could not give exact information on when rash started.  He still currently has a rash.
Age: 35.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Immediate post-injection reaction, Paraesthesia
Clinical narrative: Patient reported tingling in her arm right after the covid vaccine, patient also received a flu vaccine in the same arm immediately after the covid vaccine. She described no issues in range of motion of her shoulder, just a tingling sensation similar to when one's arm has that "falling asleep" feeling
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dysstasia, Swelling
Clinical narrative: All my joints are hurting, no fever, mild swelling.  I have been using ibuprofen 800 mg 3x daily with minimal relief. This pain is close to my crps diagnosis. I cannot get out of chair, car, stand very long, basically stuck because joints hurting so bad
Age: 73.0
Sex: M
Vaccine: FLU4
Symptoms: Device connection issue, Syringe issue, Underdose
Clinical narrative: Pt had appointment for 3 vaccines: RSV, COVID, and flu. Most of the flu vaccine came out around the Luer-Lok needle. The pt said he did not feel vaccine enter his arm. The pt was scheduled to get valid dose one week later. PCP was contacted and did not want him to have another flu vaccine at this time.
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Feeling cold, Feeling jittery, Nervousness
Clinical narrative: Could not get warm, jumpy/jittery, weak
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Chest pain, Dyspnoea, Pulmonary embolism
Clinical narrative: Shortness of breath and chest burning upon exertion three days ago. PCP appointment today and referred to emergency department. He was found to have multilobar pulmonary emboli on CTA Chest. Currently on Heparin infusion, awaiting echocardiogram and venous ultrasound doppler of bilateral lower extremities. Potential for embolectomy.
Age: 53.0
Sex: F
Vaccine: PNC20, VARZOS
Symptoms: Injection site swelling, Peripheral swelling
Clinical narrative: SWELLING AT INJECTION SITE WITH  ADDITIONAL SWELLING TOWARD HAND
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Blood sodium decreased, COVID-19, Chest X-ray abnormal, Computerised tomogram thorax normal, Cough
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/10/2023 Discharge Date: 7/15/2023 Discharge Disposition:  home health care svc   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 [U07.1]   HOSPITAL COURSE:  Patient is 87-year-old female PMH significant for CKD stage 4, chronic diastolic HF, paroxysmal AFib, hypertension--presents to the hospital 7/10 with complaints of dyspnea.  Patient had flu-like symptoms, nausea, vomiting, diarrhea and cough about 11 days prior to admit and tested positive for COVID-19.  She tried to nurse herself at home but did not notice any improvement over several days.  She continued to have progressive dyspnea, especially about 5 days prior to presentation, ongoing poor oral intake. Patient was noted to be hypoxic in ER and was placed on supplemental oxygen, along with sodium of 125.  Chest x-ray showed right lung pneumonia in left lung streaky opacity.  Film array confirmed positive COVID-19.  Patient was placed on supplemental oxygen given hypoxia and admitted to the hospital for further management of COVID infection. Patient does not qualify for remdesivir due to duration of her illness, was started on dexamethasone at 6 mg daily along with encouragement for pulmonary toilet, deep breathing/coughing, increased out of bed mobility and maintaining adequate nutrition.  She was maintained on her home dose apixaban for DVT prophylaxis.  Patient's hypoxia worsened to need Ventimask, CT thorax was obtained which was negative for any lobar consolidations and hence was not started any antibiotics.  Her procalcitonin was negative as well.  Since no clinical improvement was noted, pulmonary consultation was requested, recommended to continue with present management, possibly consideration for high-flow nasal cannula if FiO2 need> 50%/or oxygen pendant if FiO2 requirement < 40%, instead of Ventimask.  Will need outpatient repeat CT for follow-up in 2-3 months.  Commented on other available therapies including remdesivir (if patient gets worse), baricitinib, antibiotics, diuretics etc..  Oxygen needs however started to improve by 7/14, pulmonary rehab consulted and recommended d/c home with 3L at rest and 6L with activity. Portable O2 tank dropped off too room and pt discharged home in stable condition on 7/15. HHC was arranged for her ongoing home therapy.   Her presenting symptoms of nausea, vomiting and diarrhea mostly resolved. Renal function consistent with her stage IV CKD, remained stable. Atrial fibrillation also states stable, maintained on anticoagulation
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Hypophagia, Hypoxia, Influenza like illness
Clinical narrative: BRIEF OVERVIEW: Admission Date: 7/10/2023 Discharge Date: 7/15/2023 Discharge Disposition:  home health care svc   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 [U07.1]   HOSPITAL COURSE:  Patient is 87-year-old female PMH significant for CKD stage 4, chronic diastolic HF, paroxysmal AFib, hypertension--presents to the hospital 7/10 with complaints of dyspnea.  Patient had flu-like symptoms, nausea, vomiting, diarrhea and cough about 11 days prior to admit and tested positive for COVID-19.  She tried to nurse herself at home but did not notice any improvement over several days.  She continued to have progressive dyspnea, especially about 5 days prior to presentation, ongoing poor oral intake. Patient was noted to be hypoxic in ER and was placed on supplemental oxygen, along with sodium of 125.  Chest x-ray showed right lung pneumonia in left lung streaky opacity.  Film array confirmed positive COVID-19.  Patient was placed on supplemental oxygen given hypoxia and admitted to the hospital for further management of COVID infection. Patient does not qualify for remdesivir due to duration of her illness, was started on dexamethasone at 6 mg daily along with encouragement for pulmonary toilet, deep breathing/coughing, increased out of bed mobility and maintaining adequate nutrition.  She was maintained on her home dose apixaban for DVT prophylaxis.  Patient's hypoxia worsened to need Ventimask, CT thorax was obtained which was negative for any lobar consolidations and hence was not started any antibiotics.  Her procalcitonin was negative as well.  Since no clinical improvement was noted, pulmonary consultation was requested, recommended to continue with present management, possibly consideration for high-flow nasal cannula if FiO2 need> 50%/or oxygen pendant if FiO2 requirement < 40%, instead of Ventimask.  Will need outpatient repeat CT for follow-up in 2-3 months.  Commented on other available therapies including remdesivir (if patient gets worse), baricitinib, antibiotics, diuretics etc..  Oxygen needs however started to improve by 7/14, pulmonary rehab consulted and recommended d/c home with 3L at rest and 6L with activity. Portable O2 tank dropped off too room and pt discharged home in stable condition on 7/15. HHC was arranged for her ongoing home therapy.   Her presenting symptoms of nausea, vomiting and diarrhea mostly resolved. Renal function consistent with her stage IV CKD, remained stable. Atrial fibrillation also states stable, maintained on anticoagulation